Dr. Patrick Godwin, M.D

NPI: 1801986351
Total Payments
$146,300
2024 Payments
$25,168
Companies
9
Transactions
226

Payment Breakdown by Category

Other$105,020 (71.8%)
Consulting$18,846 (12.9%)
Travel$14,734 (10.1%)
Food & Beverage$7,698 (5.3%)
Education$2.31 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $105,020 53 71.8%
Consulting Fee $18,846 10 12.9%
Travel and Lodging $14,734 56 10.1%
Food and Beverage $7,698 106 5.3%
Education $2.31 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $78,285 97 $0 (2021)
Gilead Sciences, Inc. $67,184 118 $0 (2024)
ABBVIE INC. $271.87 4 $0 (2022)
PORTOLA PHARMACEUTICALS, INC. $144.86 1 $0 (2018)
La Jolla Pharmaceutical Company $118.56 1 $0 (2018)
Allergan, Inc. $110.48 2 $0 (2020)
The Medicines Company $90.22 1 $0 (2017)
PFIZER INC. $81.50 1 $0 (2024)
AstraZeneca Pharmaceuticals LP $13.98 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $25,168 42 Gilead Sciences, Inc. ($25,087)
2023 $28,756 52 Gilead Sciences, Inc. ($28,742)
2022 $12,471 26 Gilead Sciences, Inc. ($12,215)
2021 $3,106 7 Janssen Pharmaceuticals, Inc ($1,950)
2020 $13,882 17 Janssen Pharmaceuticals, Inc ($13,771)
2019 $17,433 21 Janssen Pharmaceuticals, Inc ($17,433)
2018 $16,379 19 Janssen Pharmaceuticals, Inc ($16,116)
2017 $29,105 42 Janssen Pharmaceuticals, Inc ($29,015)

All Payment Transactions

226 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
11/21/2024 Gilead Sciences, Inc. Veklury (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $525.00 General
Category: COVID-19
11/19/2024 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $108.16 General
Category: COVID-19
11/11/2024 PFIZER INC. Food and Beverage In-kind items and services $81.50 General
10/01/2024 Gilead Sciences, Inc. Veklury (Drug) Consulting Fee Cash or cash equivalent $4,750.00 General
Category: COVID-19
09/12/2024 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $53.33 General
Category: COVID-19
09/12/2024 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $44.44 General
Category: COVID-19
09/12/2024 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $38.55 General
Category: COVID-19
09/12/2024 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $29.74 General
Category: COVID-19
09/11/2024 Gilead Sciences, Inc. Veklury (Drug) Travel and Lodging In-kind items and services $261.06 General
Category: COVID-19
09/11/2024 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $108.70 General
Category: COVID-19
07/17/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $145.94 General
07/15/2024 Gilead Sciences, Inc. Veklury (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: COVID-19
07/15/2024 Gilead Sciences, Inc. Veklury (Drug) Consulting Fee Cash or cash equivalent $473.00 General
Category: COVID-19
05/23/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $97.12 General
04/24/2024 Gilead Sciences, Inc. Veklury (Drug) Travel and Lodging In-kind items and services $62.42 General
Category: COVID-19
04/24/2024 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $45.92 General
Category: COVID-19
04/24/2024 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $21.08 General
Category: COVID-19
04/22/2024 Gilead Sciences, Inc. Veklury (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,230.00 General
Category: COVID-19
04/17/2024 Gilead Sciences, Inc. Veklury (Drug) Travel and Lodging In-kind items and services $846.25 General
Category: COVID-19
04/17/2024 Gilead Sciences, Inc. Veklury (Drug) Travel and Lodging In-kind items and services $605.68 General
Category: COVID-19
04/17/2024 Gilead Sciences, Inc. Veklury (Drug) Travel and Lodging In-kind items and services $289.36 General
Category: COVID-19
04/17/2024 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $72.07 General
Category: COVID-19
04/05/2024 Gilead Sciences, Inc. Veklury (Drug) Travel and Lodging In-kind items and services $91.92 General
Category: COVID-19
04/05/2024 Gilead Sciences, Inc. Veklury (Drug) Travel and Lodging In-kind items and services $17.62 General
Category: COVID-19
03/13/2024 Gilead Sciences, Inc. Veklury (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,230.00 General
Category: COVID-19

About Dr. Patrick Godwin, M.D

Dr. Patrick Godwin, M.D is a Internal Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801986351.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Godwin, M.D has received a total of $146,300 in payments from pharmaceutical and medical device companies, with $25,168 received in 2024. These payments were reported across 226 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($105,020).

Practice Information

  • Specialty Internal Medicine
  • Location Chicago, IL
  • Active Since 10/13/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1801986351

Products in Payments

  • XARELTO (Drug) $78,285
  • Veklury (Drug) $60,540
  • DALVANCE (Drug) $152.03
  • BEVYXXA (Drug) $144.86
  • AVYCAZ (Drug) $119.84
  • GIAPREZA (Drug) $118.56
  • TEFLARO (Drug) $110.48
  • VABOMERE (Drug) $90.22
  • FARXIGA (Drug) $13.98

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Chicago